What is the dosing for Anucort (hydrocortisone)

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Anucort dosing should be one suppository inserted rectally 1-2 times daily for 2-3 weeks, then reduced to every other day as symptoms improve, based on the standard treatment guidelines for anorectal conditions 1. The dosing for Anucort suppositories is typically one suppository inserted rectally 1-2 times daily for 2-3 weeks, then reduced to every other day as symptoms improve.

  • For the rectal cream formulation, a small amount (about 1 inch) is applied to the affected area 2-4 times daily.
  • Treatment duration should generally not exceed 3-4 weeks without medical supervision.
  • It's essential to use the medication after bowel movements and to clean the area before application.
  • Anucort works by reducing inflammation, itching, and swelling in the rectal area through its anti-inflammatory properties.
  • Patients should follow the complete course as prescribed even if symptoms improve quickly, and should contact their healthcare provider if symptoms worsen or don't improve after 7 days of treatment.
  • Side effects may include local irritation, burning, or itching at the application site. However, it's crucial to note that the provided evidence does not directly address Anucort dosing, but rather focuses on corticosteroid therapy for acute severe ulcerative colitis (ASUC) and management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy 1.
  • The study by the British Society of Gastroenterology provides guidelines for corticosteroid therapy, including intravenous hydrocortisone and methylprednisolone dosing, but does not specifically address Anucort dosing 1.
  • The ASCO guideline update provides information on management of immune-related adverse events, including steroid stress dosing and emergency injections, but does not directly relate to Anucort dosing 1.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Anucort Dosing

  • Anucort is a topical corticosteroid used to treat ulcerative colitis, specifically proctitis and distal ulcerative colitis 2.
  • The dosing of Anucort is not explicitly stated in the provided studies, but topical corticosteroids like Anucort are typically used as follows:
    • For proctitis, topical 5-aminosalicylic acid (5-ASA) drugs are used as the first line agents, and topical corticosteroids like Anucort may be used as an alternative or in combination with 5-ASA drugs 3, 4.
    • The dosage and duration of treatment with Anucort may vary depending on the severity and extent of the disease, as well as the patient's response to treatment 2.
  • It is essential to note that corticosteroids, including Anucort, are not recommended for long-term use as maintenance treatment due to their potential adverse effects 2.

Treatment of Ulcerative Colitis

  • The treatment of ulcerative colitis (UC) depends on the severity and extent of the disease, as well as the patient's response to treatment 3, 4.
  • For mild to moderate UC, oral 5-ASA drugs are commonly used as first-line therapy, while topical corticosteroids like Anucort may be used for proctitis or distal UC 3, 4.
  • For more severe UC, oral corticosteroids or intravenous corticosteroids may be necessary to induce remission 5, 2.

Clinical Outcomes

  • The clinical outcomes of patients with UC treated with Anucort or other topical corticosteroids are not explicitly stated in the provided studies.
  • However, studies have shown that topical corticosteroids can be effective in inducing remission in patients with mild to moderate UC, particularly those with proctitis or distal disease 4, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A current overview of corticosteroid use in active ulcerative colitis.

Expert review of gastroenterology & hepatology, 2019

Research

Standard treatment of ulcerative colitis.

Digestive diseases (Basel, Switzerland), 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.